samedan logo
 
 
spacer
home > pmps > winter 2001 > an introduction to transdermal drug delivery systems
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

An Introduction to Transdermal Drug Delivery Systems

In the first part of this article in the Autumn 2001 issue of PMPS, we analysed the varieties, the structure and the basic components of patches. This 'promenade' was important in order to better understand how these drug delivery systems are composed. In this second part we will follow the processes involved in the production of the two major classes, matrix and liquid reservoir patches. We will then finish with a detailed description of the whole production chain for the most popular class at present - the matrix systems.

Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Spyridon A. Fotinos, Executive Vice President - Corporate Research & Innovation, at Lavipharm Group of Companies
Spyridon Fotinos studied pharmaceutics at the University of Athens, before going on to study chemistry at the University of Thessaloniki. He joined Lavipharm in 1979, and in 1987, established the Research and Development Department, of which he has since become a Director.
Spyridon's current position is Executive Vice President - Corporate Research and Innovation. Prior to his time at Lavipharm, he served for four years as Director of Planning and Studies at Minerva Pharmaceuticals. Spyridon is a patent holder in the areas of pharmaceutical and cosmetic delivery technology, antioxidant and enzymic systems. He is also a member of several Greek and international scientific organisations.

spacer
Spyridon A. Fotinos
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Small Scale Biomanufacturing – clinical trials, cell & gene therapies

18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol

This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >>

 
News and Press Releases

Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement